Artiva Biotherapeutics

View the org chart displaying its 18 main executives

Most searched biographies at Artiva Biotherapeutics

• Fred Aslan, Director, President and Chief Executive Officer
• Brian Daniels, Chairman of the Board
• Yvonne Yamanaka, Director

Popular executive movements at Artiva Biotherapeutics

• Neha Krishnamohan has joined the company as Chief Financial Officer and Executive Vice President, Corporate Development  (posted on April 26 2024).

Create your alert
to follow the executive moves at Artiva Biotherapeutics.

Artiva Biotherapeutics has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Johnson & Johnson has announced the acquisition of Proteologix  (posted on May 20 2024).
• Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Artiva Biotherapeutics

• Artiva NK Cell Therapy News
• Press Releases

Social media about Artiva Biotherapeutics

• Artiva Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Artiva Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Fred Aslan

Call Artiva Biotherapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error